{"id":"https://openalex.org/W3172367804","doi":"https://doi.org/10.2174/2666796702666210601125131","title":"Immunosuppressant Drugs and Covid-19: Associated Risks, Drug-Drug Interactions and Contraindications","display_name":"Immunosuppressant Drugs and Covid-19: Associated Risks, Drug-Drug Interactions and Contraindications","publication_year":2021,"publication_date":"2021-06-02","ids":{"openalex":"https://openalex.org/W3172367804","doi":"https://doi.org/10.2174/2666796702666210601125131","mag":"3172367804"},"language":"en","primary_location":{"id":"doi:10.2174/2666796702666210601125131","doi":"https://doi.org/10.2174/2666796702666210601125131","is_oa":false,"landing_page_url":"https://doi.org/10.2174/2666796702666210601125131","pdf_url":null,"source":{"id":"https://openalex.org/S4210231798","display_name":"Coronaviruses","issn_l":"2666-7967","issn":["2666-7967","2666-7975"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","norway-1"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Coronaviruses","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5107223559","display_name":"Debjyoti Talukdar","orcid":"https://orcid.org/0000-0003-0698-1957","observed_orcids":["https://orcid.org/0000-0003-0698-1957"]},"institutions":[{"id":"https://openalex.org/I134705546","display_name":"Teerthanker Mahaveer University","ror":"https://ror.org/04vkd2013","country_code":"IN","type":"education","lineage":["https://openalex.org/I134705546"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Debjyoti Talukdar","raw_affiliation_strings":["Teerthanker Mahaveer College of Pharmacy, Moradabad, Uttar Pradesh, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Teerthanker Mahaveer College of Pharmacy, Moradabad, Uttar Pradesh, India","institution_ids":["https://openalex.org/I134705546"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010458698","display_name":"Diane Ignacio","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088717","display_name":"University of the West Indies","ror":"https://ror.org/003kgv736","country_code":"TT","type":"education","lineage":["https://openalex.org/I137799390","https://openalex.org/I4210088717"]}],"countries":["TT"],"is_corresponding":false,"raw_author_name":"Diane Ignacio","raw_affiliation_strings":["School of Pharmacy, Faculty of Medical Sciences, The University of the West Indies, St. Augustine, Trinidad and Tobago, West Indies"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Pharmacy, Faculty of Medical Sciences, The University of the West Indies, St. Augustine, Trinidad and Tobago, West Indies","institution_ids":["https://openalex.org/I4210088717"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5042824986","display_name":"Madan M. Gupta","orcid":"https://orcid.org/0000-0002-5224-4774","observed_orcids":["https://orcid.org/0000-0002-5224-4774"]},"institutions":[{"id":"https://openalex.org/I4210088717","display_name":"University of the West Indies","ror":"https://ror.org/003kgv736","country_code":"TT","type":"education","lineage":["https://openalex.org/I137799390","https://openalex.org/I4210088717"]}],"countries":["TT"],"is_corresponding":true,"raw_author_name":"Madan Mohan Gupta","raw_affiliation_strings":["School of Pharmacy, Faculty of Medical Sciences, The University of the West Indies, St. Augustine, Trinidad and Tobago, West Indies"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Pharmacy, Faculty of Medical Sciences, The University of the West Indies, St. Augustine, Trinidad and Tobago, West Indies","institution_ids":["https://openalex.org/I4210088717"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5042824986"],"corresponding_institution_ids":["https://openalex.org/I4210088717"],"apc_list":null,"apc_paid":null,"fwci":0.1701,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":{"value":0.51261731,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"2","issue":"12","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10041","display_name":"COVID-19 Clinical Research Studies","score":0.9369999766349792,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10041","display_name":"COVID-19 Clinical Research Studies","score":0.9369999766349792,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","score":0.048900000751018524,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.0026000000070780516,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/immunosuppressive-drugs","display_name":"immunosuppressants","score":0.8980000019073486},{"id":"https://openalex.org/keywords/covid-19","display_name":"COVID-19 pandemic","score":0.9819999933242798},{"id":"https://openalex.org/keywords/sars-cov-2","display_name":"SARS-CoV-2","score":0.9769999980926514},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.8849999904632568},{"id":"https://openalex.org/keywords/contraindications","display_name":"contraindications","score":0.8240000009536743},{"id":"https://openalex.org/keywords/immunocompromised-patients","display_name":"immunocompromised patients","score":0.8610000014305115},{"id":"https://openalex.org/keywords/etanercept","display_name":"etanercept","score":0.8389999866485596},{"id":"https://openalex.org/keywords/mycophenolate-mofetil","display_name":"mycophenolate mofetil","score":0.9990000128746033},{"id":"https://openalex.org/keywords/rapamycin","display_name":"rapamycin","score":1.0},{"id":"https://openalex.org/keywords/cyclosporine","display_name":"cyclosporine","score":0.9980000257492065},{"id":"https://openalex.org/keywords/rituximab","display_name":"rituximab","score":1.0},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.9300000071525574},{"id":"https://openalex.org/keywords/autoimmune-disease","display_name":"autoimmune disease","score":0.6499999761581421},{"id":"https://openalex.org/keywords/transplant-recipients","display_name":"transplant recipients","score":0.7960000038146973},{"id":"https://openalex.org/keywords/cancer-therapy","display_name":"cancer therapy","score":0.6200000047683716},{"id":"https://openalex.org/keywords/covid-19-risk-factors","display_name":"COVID-19 risk factors","score":0.8009999990463257}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.817136824131012},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.6610614061355591},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.5637762546539307},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.5070211887359619},{"id":"https://openalex.org/C2779756493","wikidata":"https://www.wikidata.org/wiki/Q846227","display_name":"Antiviral drug","level":3,"score":0.4749993085861206},{"id":"https://openalex.org/C138816342","wikidata":"https://www.wikidata.org/wiki/Q189603","display_name":"Public health","level":2,"score":0.464677631855011},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.464664101600647},{"id":"https://openalex.org/C89623803","wikidata":"https://www.wikidata.org/wiki/Q12184","display_name":"Pandemic","level":5,"score":0.43972572684288025},{"id":"https://openalex.org/C3008058167","wikidata":"https://www.wikidata.org/wiki/Q84263196","display_name":"Coronavirus disease 2019 (COVID-19)","level":4,"score":0.34178587794303894},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.30911779403686523},{"id":"https://openalex.org/C524204448","wikidata":"https://www.wikidata.org/wiki/Q788926","display_name":"Infectious disease (medical specialty)","level":3,"score":0.24071690440177917},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.19683119654655457},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.2174/2666796702666210601125131","doi":"https://doi.org/10.2174/2666796702666210601125131","is_oa":false,"landing_page_url":"https://doi.org/10.2174/2666796702666210601125131","pdf_url":null,"source":{"id":"https://openalex.org/S4210231798","display_name":"Coronaviruses","issn_l":"2666-7967","issn":["2666-7967","2666-7975"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","norway-1"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Coronaviruses","raw_type":"journal-article"},{"id":"doi:10.22541/au.160091464.40011130","doi":"https://doi.org/10.22541/au.160091464.40011130","is_oa":false,"landing_page_url":"https://doi.org/10.22541/au.160091464.40011130","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"posted-content"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":32,"referenced_works":["https://openalex.org/W2007386646","https://openalex.org/W2106444498","https://openalex.org/W3001465255","https://openalex.org/W3005212621","https://openalex.org/W3006645647","https://openalex.org/W3009828946","https://openalex.org/W3010426650","https://openalex.org/W3010776300","https://openalex.org/W3011072970","https://openalex.org/W3012421327","https://openalex.org/W3013667078","https://openalex.org/W3014050022","https://openalex.org/W3014108891","https://openalex.org/W3014327364","https://openalex.org/W3014393381","https://openalex.org/W3015016176","https://openalex.org/W3015480280","https://openalex.org/W3015490759","https://openalex.org/W3015899180","https://openalex.org/W3016134587","https://openalex.org/W3016244152","https://openalex.org/W3016271633","https://openalex.org/W3016308590","https://openalex.org/W3016360415","https://openalex.org/W3016413978","https://openalex.org/W3021578849","https://openalex.org/W3023108443","https://openalex.org/W3024776466","https://openalex.org/W3025456982","https://openalex.org/W4206188795","https://openalex.org/W4241546886","https://openalex.org/W4406746698"],"related_works":["https://openalex.org/W3089179323","https://openalex.org/W3082474050","https://openalex.org/W4283778244","https://openalex.org/W4244021479","https://openalex.org/W3194770984","https://openalex.org/W4249553250","https://openalex.org/W3205805974","https://openalex.org/W3120554183","https://openalex.org/W3138486719","https://openalex.org/W3080416484"],"abstract_inverted_index":{":":[0],"Immunosuppressant":[1],"drugs":[2,25,64],"like":[3],"Etanercept,":[4],"Mycophenolate":[5],"mofetil,":[6],"Sirolimus,":[7],"Cyclosporine,":[8],"and":[9,16,42,65,81,90,93,118,127,152,161],"Rituximab":[10],"can":[11,38,49],"weaken":[12],"the":[13,60,74,159,165,168],"immune":[14,47],"system":[15,48],"make":[17,26],"patients":[18,155],"susceptible":[19],"to":[20,31,51,131],"SARS":[21],"nCoV-2":[22],"virus.":[23],"These":[24],"immunocompromised":[27],"persons":[28],"more":[29],"vulnerable":[30],"complications":[32],"associated":[33,67,111,136,163],"with":[34,70,137,164],"COVID-19.":[35],"Moreover,":[36,99],"it":[37,100],"also":[39,101],"increase":[40],"mortality":[41,160],"morbidity,":[43],"as":[44],"a":[45,52],"weakened":[46],"lead":[50],"longer":[53],"duration":[54],"of":[55,108],"infection.":[56],"This":[57],"study":[58,122],"discusses":[59],"guidelines":[61],"on":[62],"immunosuppressant":[63],"their":[66],"risk":[68,112],"factors":[69],"COVID-19,":[71],"issued":[72],"by":[73],"U.S":[75,87],"CDC":[76],"(Centers":[77],"for":[78,146],"Disease":[79],"Control":[80],"Prevention),":[82],"WHO":[83],"(World":[84],"Health":[85],"Organization),":[86],"FDA":[88],"(Food":[89],"Drug":[91],"Administration),":[92],"other":[94],"accredited":[95],"global":[96],"health":[97,129,134],"organizations.":[98],"includes":[102],"information":[103],"about":[104,142],"pharmaceutical":[105],"properties,":[106],"mechanism":[107],"action,":[109],"COVID-19":[110,133,169],"factors,":[113],"adverse":[114],"drug":[115,144],"reactions,":[116],"contraindications,":[117],"drug-drug":[119],"interactions.":[120],"Our":[121],"will":[123,156],"help":[124,157],"government":[125],"partners":[126],"international":[128],"organizations":[130],"understand":[132],"risks":[135],"immunosuppressants.":[138],"Increased":[139],"public":[140],"awareness":[141],"effective":[143],"therapy":[145],"autoimmune":[147],"diseases,":[148],"cancer":[149],"treatment,":[150],"immunocompromised,":[151],"organ":[153],"transplant":[154],"lower":[158],"morbidity":[162],"disease":[166],"amid":[167],"pandemic.":[170]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1}],"updated_date":"2026-11-09T13:22:03.289127","created_date":"2021-06-22T00:00:00"}